22 related articles for article (PubMed ID: 22056261)
1. Enhancing anti-tumor potential: low-intensity vibration suppresses osteosarcoma progression and augments MSCs' tumor-suppressive abilities.
Xiong X; Huo Q; Li K; Cui C; Chang C; Park C; Ku B; Hong CS; Lim H; Pandya PH; Saadatzadeh MR; Bijangi-Vishehsaraei K; Lin CC; Kacena MA; Pollok KE; Chen A; Liu J; Thompson WR; Li XL; Li BY; Yokota H
Theranostics; 2024; 14(4):1430-1449. PubMed ID: 38389836
[No Abstract] [Full Text] [Related]
2. Clemastine and hyperthermia enhance sensitization of osteosarcoma cells for apoptosis.
Obu S; Niture S; Hoang H; Gadi S; Vandana ; He Y; Kumar D
Mol Cell Oncol; 2024; 11(1):2351622. PubMed ID: 38778919
[TBL] [Abstract][Full Text] [Related]
3. The Biological Impact of Some Phosphonic and Phosphinic Acid Derivatives on Human Osteosarcoma.
Khaled Z; Ilia G; Watz C; Macașoi I; Drăghici G; Simulescu V; Merghes PE; Varan NI; Dehelean CA; Vlaia L; Sima L
Curr Issues Mol Biol; 2024 May; 46(5):4815-4831. PubMed ID: 38785558
[TBL] [Abstract][Full Text] [Related]
4. Myoepithelial and luminal breast cancer cells exhibit different responses to all-trans retinoic acid.
Berardi DE; Flumian C; Campodónico PB; Urtreger AJ; Diaz Bessone MI; Motter AN; Bal de Kier Joffé ED; Farias EF; Todaro LB
Cell Oncol (Dordr); 2015 Aug; 38(4):289-305. PubMed ID: 26044847
[TBL] [Abstract][Full Text] [Related]
5. LOX/COX inhibitors enhance the antineoplastic effects of all-trans retinoic acid in osteosarcoma cell lines.
Krzyzankova M; Chovanova S; Chlapek P; Radsetoulal M; Neradil J; Zitterbart K; Sterba J; Veselska R
Tumour Biol; 2014 Aug; 35(8):7617-27. PubMed ID: 24798977
[TBL] [Abstract][Full Text] [Related]
6. An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.
Safari M; Khoshnevisan A
World J Stem Cells; 2014 Jan; 6(1):53-64. PubMed ID: 24567788
[TBL] [Abstract][Full Text] [Related]
7. Mesenchymal stem cells engineered for cancer therapy.
Shah K
Adv Drug Deliv Rev; 2012 Jun; 64(8):739-48. PubMed ID: 21740940
[TBL] [Abstract][Full Text] [Related]
8. [Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS].
Ye ZM; Miao XD; Yang DS; Xu RZ; Huang X; Ge FF
Ai Zheng; 2005 Mar; 24(3):298-304. PubMed ID: 15757530
[TBL] [Abstract][Full Text] [Related]
9. A search for multidrug resistance modulators: the effects of retinoids in human colon carcinoma cells.
Bartolini G; Orlandi M; Papi A; Ammar K; Guerra F; Ferreri AM; Rocchi P
In Vivo; 2006; 20(6A):729-33. PubMed ID: 17203756
[TBL] [Abstract][Full Text] [Related]
10. [Synergistic inhibitory effect of all-trans retinoic acid and 1,25-dihydroxy vitamin D3 on growth of human hepatoma cell line HepG2].
Lu HQ; Zheng J
Ai Zheng; 2006 Dec; 25(12):1470-6. PubMed ID: 17166369
[TBL] [Abstract][Full Text] [Related]
11. Novel quinazoline HMJ-30 induces U-2 OS human osteogenic sarcoma cell apoptosis through induction of oxidative stress and up-regulation of ATM/p53 signaling pathway.
Chiu YJ; Hour MJ; Lu CC; Chung JG; Kuo SC; Huang WW; Chen HJ; Jin YA; Yang JS
J Orthop Res; 2011 Sep; 29(9):1448-56. PubMed ID: 21425328
[TBL] [Abstract][Full Text] [Related]
12. All-trans retinoic acid arrests neuroblastoma cells in a dormant state. Subsequent nerve growth factor/brain-derived neurotrophic factor treatment adds modest benefit.
Cernaianu G; Brandmaier P; Scholz G; Ackermann OP; Alt R; Rothe K; Cross M; Witzigmann H; Tröbs RB
J Pediatr Surg; 2008 Jul; 43(7):1284-94. PubMed ID: 18639684
[TBL] [Abstract][Full Text] [Related]
13. Cell growth inhibition and apoptotic effect of the rexinoid 6-OH-11-O-hydroxyphenantrene on human osteosarcoma and mesenchymal stem cells.
Dozza B; Papi A; Lucarelli E; Scotlandi K; Pierini M; Tresca G; Donati D; Orlandi M
Toxicol In Vitro; 2012 Feb; 26(1):142-9. PubMed ID: 22056261
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
